Welcome to CDC Stacks | Interim laboratory biosafety guidelines for handling and processing specimens associated with Severe Acute Respiratory Syndrome (SARS): March 22, 2003 - 25036 | Health Alert Network (HAN)
Stacks Logo
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
Help
Clear All Simple Search
Advanced Search
Interim laboratory biosafety guidelines for handling and processing specimens associated with Severe Acute Respiratory Syndrome (SARS): March 22, 2003
  • Published Date:
    3/22/03
  • Source:
    HAN ; 124
  • Language:
    English
Filetype[PDF - 623.28 KB]


Details:
  • Supporting Files:
    No Additional Files
No Related Documents.
You May Also Like:
  1. Interim laboratory biosafety guidelines for handling and processing specimens associated with severe acute respiratory syndrome (SARS)
    Corporate Author:
    Centers for Disease Control and Prevention (U.S.)
    Published:
    April 2, 2003
    Source:
    Severe acute respiratory syndrome
    Description:
    The Centers for Disease Control and Prevention (CDC) and the World Health Organization have received reports of patients with Severe Acute Respiratory Syndrome (SARS) from various international and domestic sources. The cause of these illnesses is un...
    File Type:
    Filetype[PDF - 1.46 MB]
  2. Interim laboratory biosafety guidelines for handling and processing specimens associated with Middle East Respiratory Syndrome
    Corporate Author:
    Centers for Disease Control and Prevention (U.S.)
    Published:
    June 7, 2013
    Description:
    To date, little is known about pathogenic potential and transmission dynamics of Middle East Respiratory Syndrome Coronavirus (MERS-CoV). Until more information becomes available, precautions should be taken in collecting and handling specimens that ...
    File Type:
    Filetype[PDF - 77.49 KB]
  3. Laboratory biosafety guidelines for handling and processing specimens associated with SARS-CoV
    Corporate Author:
    Centers for Disease Control and Prevention (U.S.)
    Published:
    January 8, 2004
    Source:
    Severe acute respiratory syndrome ; Public health guidance for community-level preparedness and response to severe acute respiratory syndrome (SARS) Version 2. Supplement F: Laboratory guidance appendix F5 ;
    Description:
    Although routine clinical laboratories around the world have processed an estimated several thousand diagnostic specimens from patients with SARS, no cases of SARS-CoV disease among laboratory workers performing diagnostic assays have been reported t...
    File Type:
    Filetype[PDF - 88.98 KB]
  4. Updated interim surveillance case definition for severe acute respiratory syndrome (SARS)--United States, April 29, 2003
    Corporate Author:
    Centers for Disease Control and Prevention (U.S.)
    Published:
    April 29, 2003
    Series:
    MMWR dispatch ; v. 52, April 29, 2003
    Description:
    CDC's interim surveillance case definition for severe acute respiratory syndrome (SARS) has been updated to include laboratory criteria for evidence of infection with the SARS-associated coronavirus (SARS-CoV) (Figure, Box). In addition, clinical cri...
    File Type:
    Filetype[PDF - 82.92 KB]
  5. Laboratory management of agents associated with hantavirus pulmonary syndrome; interim biosafety guidelines
    Personal Author:
    Knudsen, Richard C. ; Mathews, Henry M. ; Richmond, Jonathan Y. ; Craven, Robert B. ; Garner, Julia S. ; Karabatsos, Nick; Khabbaz, Rima F.; Ksiazek, Thomas G. ; Kuno, Goro; Mahy, Brian W. J. ; Peters, C. J. (Clarence James), 1940-; Rollin, Pierre E. ;
    Corporate Author:
    Centers for Disease Control and Prevention (U.S.); American Society of Tropical Medicine and Hygiene. Subcommittee on Arbovirus Laboratory Safety.;
    Published:
    May 13, 1994
    Source:
    MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports / Centers for Disease Control. 1994; 43(RR-7):1-7.
    Series:
    MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports ; v. 43, no. RR-7
    Description:
    "This report provides interim biosafety guidelines for preventing laboratory-associated infections with agents that cause hantavirus pulmonary syndrome. The guidelines are based on extensive laboratory experience with the other hantaviruses--particul...
    Status:
    current
    File Type:
    Filetype[PDF - 139.44 KB]